Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Saurabh Gupta

Vascular Surgery Baltimore, MD Medical Doctor

NPI 1770934788 CMS profile 2352708

22 S Greene St # S10b00, Baltimore, MD 21201

Open in the dashboard

General payments

$30,918

161 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Saurabh Gupta of Baltimore, MD is reported in the CMS Open Payments database as having received $30,918 across 161 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,943 70
2024 General $1,671 20
2023 General $7,973 35
2022 General $3,721 33
2021 General $611 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Saurabh Gupta
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Saurabh Gupta were reported at $16,943. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Saurabh Gupta Vascular Surgery median Middle half National median
2019 $0 $796 $226–$2,363 $163
2020 $0 $348 $118–$1,110 $114
2021 $611 $471 $158–$1,421 $132
2022 $3,721 $725 $222–$2,183 $149
2023 $7,973 $836 $257–$2,440 $160
2024 $1,671 $909 $252–$2,619 $164
2025 $16,943 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $15,363 39 payments
  2. Philips Electronics North America Corporation $5,708 13 payments
  3. W. L. Gore & Associates, Inc. $3,683 35 payments
  4. Bolton Medical Inc $2,565 34 payments
  5. Endologix, Inc. $1,109 10 payments
  6. Boston Scientific Corporation $523 8 payments
  7. Abbott Laboratories $423 3 payments
  8. Terumo Medical Corporation $388 6 payments
  9. LeMaitre Vascular, Inc. $219 2 payments
  10. Silk Road Medical, Inc. $196 1 payment
  11. Other $742 10 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $14,506 23 payments
  2. Food and Beverage $10,983 133 payments
  3. Consulting Fee $3,188 1 payment
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,700 1 payment
  5. Education $543 3 payments
Products named General payments · program years 2021–2025
  1. Valiant Captivia $10,994 19 payments
  2. (9520) IGT Devices Undivided $5,271 12 payments
  3. ENDURANT IIS $2,671 11 payments
  4. TREO ABDOMINAL STENT-GRAFT SYSTEM $1,326 16 payments
  5. COREVALVE EVOLUT R $1,112 3 payments
  6. Grafts $1,036 14 payments
  7. Product in Development $1,018 6 payments
  8. EXCLUDER Conformable AAA Endoprosthesis with Active Control $732 7 payments
  9. Alto Abdominal Stent Graft System $722 6 payments
  10. GORE TAG Thoracic Branch Endoprosthesis $562 2 payments
  11. Other $5,187 67 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 123 billing codes

Paid by Medicare

$263,601

Medicare's payments for the services billed

Medicare patients

498

Average age 73

Services billed

938

223 women, 275 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 59%
Arthritis 53%
Diabetes 50%
Chronic kidney disease 47%
Heart failure 34%
COPD 32%
Atrial fibrillation 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

161 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record